A Phase I Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors.
Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2012
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Lymphoma; Solid tumours
- Focus Therapeutic Use
- 28 Jul 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual initiation date (Mar 2012) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.